ProQR Therapeutics Shares Sold Off Throughout Tuesday's Trading Session Following 10% After-Hours Move Higher Mon. Amid Data For QR-010 Phase 1b Trial; Stock Down 12+% Tues. Afternoon; Leerink, HC Wainwright Each Made Positive Comments Earlier
Paul Quintaro